Evidence map›Paper›PMID 32183148›Full record

ArticleBiomolecules2020

Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics in Murine Colon Cancer Cells.

Fiona Augsburger, Elisa B Randi, Mathieu Jendly, Kelly Ascencao, Nahzli Dilek, Csaba Szabo

Abstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Dual targeting of HHeliyon · 2023
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fiona AugsburgerChair of Pharmacology, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland.ORCID 0000-0001-8357-6766
Elisa B RandiChair of Pharmacology, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland.
Mathieu JendlyChair of Pharmacology, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland.
Kelly AscencaoChair of Pharmacology, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland.
Nahzli DilekChair of Pharmacology, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland.
Csaba SzaboChair of Pharmacology, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland.

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 31003A_179434
6 · The paper itself

Abstract

3-mercaptopyruvate sulfurtransferase (3-MST) has emerged as one of the significant sources of biologically active sulfur species in various mammalian cells. The current study was designed to investigate the functional role of 3-MST's catalytic activity in the murine colon cancer cell line CT26. The novel pharmacological 3-MST inhibitor HMPSNE was used to assess cancer cell proliferation, migration and bioenergetics in vitro. Methods included measurements of cell viability (MTT and LDH assays), cell proliferation and in vitro wound healing (IncuCyte) and cellular bioenergetics (Seahorse extracellular flux analysis). 3-MST expression was detected by Western blotting; H

Indexed as

Cell MovementCell ProliferationOxidative PhosphorylationAnimalsCell Line, TumorColonic NeoplasmsMiceNeoplasm ProteinsSulfurtransferases3-mercaptopyruvate sulphurtransferaseNeoplasm ProteinsSulfurtransferasesbioenergeticsgasotransmittershydrogen sulfidemigrationmitochondrianitric oxideproliferation

Identifiers

PMID32183148
PMCPMC7175125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.